In neonates with cancer and hyperleukocytosis, we believe that a RBC transfusion should be given with restraint unless there are severe clinical signs of anemia or in case of an Hb below 5.5 mmol/L in neonates with cancer when they are less than 1 week old. This evidence concerns the gene GSTM1 and cancer.